Cookson Peirce & Co. Inc. Takes $2.67 Million Position in Lantheus Holdings, Inc. $LNTH

Cookson Peirce & Co. Inc. purchased a new stake in Lantheus Holdings, Inc. (NASDAQ:LNTH) in the 2nd quarter, HoldingsChannel.com reports. The fund purchased 24,060 shares of the medical equipment provider’s stock, valued at approximately $2,669,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in LNTH. Penn Capital Management Company LLC acquired a new position in Lantheus during the second quarter worth $17,089,000. Hsbc Holdings PLC purchased a new position in shares of Lantheus during the 2nd quarter worth $2,273,000. Empowered Funds LLC purchased a new stake in shares of Lantheus in the second quarter valued at about $270,000. Equitable Holdings Inc. acquired a new stake in Lantheus during the second quarter worth about $244,000. Finally, Centaurus Financial Inc. acquired a new stake in Lantheus during the second quarter worth about $667,000. Institutional investors and hedge funds own 99.06% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the stock. William Blair set a $102.50 price target on shares of Lantheus in a report on Monday, August 3rd. B. Riley Financial lowered Lantheus from a “buy” rating to a “hold” rating in a research report on Monday, August 17th. Citizens Jmp reissued a “market outperform” rating and set a $115.00 target price on shares of Lantheus in a research note on Monday, June 29th. Mizuho reduced their target price on Lantheus from $120.00 to $115.00 and set an “outperform” rating on the stock in a research report on Wednesday, July 29th. Finally, Truist Financial downgraded Lantheus from a “buy” rating to a “hold” rating and reduced their target price for the company from $125.00 to $102.50 in a research report on Monday, August 3rd. Four analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $108.11.

Lantheus Price Performance

Lantheus stock opened at $100.77 on Friday. The company’s 50 day simple moving average is $103.74 and its 200-day simple moving average is $91.58. The company has a market capitalization of $6.58 billion, a price-to-earnings ratio of 24.34 and a beta of -0.03. Lantheus Holdings, Inc. has a 1 year low of $49.67 and a 1 year high of $111.86. The company has a debt-to-equity ratio of 0.43, a quick ratio of 2.89 and a current ratio of 3.06.

Lantheus (NASDAQ:LNTH) last issued its quarterly earnings data on Thursday, August 6th. The medical equipment provider reported $1.55 EPS for the quarter, topping the consensus estimate of $1.30 by $0.25. The firm had revenue of $388.18 million for the quarter, compared to analyst estimates of $363.23 million. Lantheus had a net margin of 17.69% and a return on equity of 28.10%. The business’s revenue for the quarter was up 2.7% compared to the same quarter last year. During the same period in the prior year, the business posted $1.57 EPS. As a group, equities research analysts expect that Lantheus Holdings, Inc. will post 4.48 earnings per share for the current year.

About Lantheus

Lantheus Holdings, Inc is a global life sciences company specializing in the development, manufacturing and commercialization of diagnostic imaging agents and radiopharmaceuticals. Headquartered in North Billerica, Massachusetts, Lantheus focuses on products that enhance the detection and management of cardiovascular and oncologic diseases. The company’s portfolio spans ultrasound-enhancing agents, molecular imaging tracers for positron emission tomography (PET), and emerging theranostic platforms designed to pair diagnostic and therapeutic applications.

The diagnostic imaging segment includes ultrasound contrast agents such as DEFINITY® (perflutren lipid microsphere) and Sonazoid® (perflubutane), which improve the visualization of cardiac structures and blood flow.